Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative subanesthetic esketamine for postoperative sleep after total joint arthroplasty
ChiCTR2500099848Phase 4Not yet recruiting
- Sponsor
- Peking University Shenzhen Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Postoperative sleep disturbance (PSD) (2 arms), sponsored by Peking University Shenzhen Hospital. Primary endpoint: Richards-Campbell Sleep Questionnaire score on the first night after surgery. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative sleep disturbance (PSD)
Beyond the preview
Go deeper on ChiCTR2500099848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099848.